European Market Infrastructure Regulation

ESMA Recognizes OCC as Tier 1 Third-Country Central Counterparty Under EMIR

Retrieved on: 
Thursday, June 30, 2022
Banking, Other Professional Services, Professional Services, Finance, CCP, Options Clearing Corporation, CFTC, Federal Reserve Board of Governors, European Commission, Growth, Federal Reserve, U.S. Securities and Exchange Commission, European Securities and Markets Authority, OCC, Structure of the Federal Reserve System, CCPS, Royal commission, European Market Infrastructure Regulation, EMIR, SEC, House, Board, ESMA, Capital Markets Authority of Saudi Arabia, Bank

OCC, the world's largest equity derivatives clearing organization, today announced that the European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has granted recognition to OCC as a Tier 1 third-country central counterparty (TC-CCP) under Article 25 of the European Market Infrastructure Regulation (EMIR).

Key Points: 
  • OCC, the world's largest equity derivatives clearing organization, today announced that the European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has granted recognition to OCC as a Tier 1 third-country central counterparty (TC-CCP) under Article 25 of the European Market Infrastructure Regulation (EMIR).
  • We are gratified that our current and future clearing members affiliated with European banks have clarity on the regulatory treatment of their exposures to OCC.
  • The Options Clearing Corporation (OCC), named Risk Magazines 2022 Clearing House of the Year, is the world's largest equity derivatives clearing organization.
  • OCC has more than 100 clearing members and provides central counterparty (CCP) clearing and settlement services to 19 exchanges and trading platforms.

Timecho, Founded by the Creators of Apache IoTDB, Raises Over US$10 Million First Fund for Open-Source Software R&D and Time-Series Database Solutions

Retrieved on: 
Wednesday, June 29, 2022
ICDE, Industry, VLDB, SIGMOD, Internet of things, European Market Infrastructure Regulation, Software, Data management, PMC, Solution, Database, Apache, IOT, European Economic Area, Typesetting

Time series database has thrived in recent years to meet new data management requirements for the Internet of Things (IoT) era.

Key Points: 
  • Time series database has thrived in recent years to meet new data management requirements for the Internet of Things (IoT) era.
  • Developers are seeking a database that can optimize data ingestion rates, storage compression as well as query and analytics features that match the needs of their time-stamped data applications.
  • "With the funding, we will be able to accelerate R&D to help developers and companies best leverage the power of Apache IoTDB."
  • Timecho will focus on providing solutions that will be more adaptable with high-end equipment, mass devices, computational-resource-limited platforms, and further scenarios.

Timecho, Founded by the Creators of Apache IoTDB, Raises Over US$10 Million First Fund for Open-Source Software R&D and Time-Series Database Solutions

Retrieved on: 
Wednesday, June 29, 2022
ICDE, Industry, VLDB, SIGMOD, Internet of things, European Market Infrastructure Regulation, Software, Data management, PMC, Solution, Database, Apache, IOT, European Economic Area, Typesetting

Time series database has thrived in recent years to meet new data management requirements for the Internet of Things (IoT) era.

Key Points: 
  • Time series database has thrived in recent years to meet new data management requirements for the Internet of Things (IoT) era.
  • Developers are seeking a database that can optimize data ingestion rates, storage compression as well as query and analytics features that match the needs of their time-stamped data applications.
  • "With the funding, we will be able to accelerate R&D to help developers and companies best leverage the power of Apache IoTDB."
  • Timecho will focus on providing solutions that will be more adaptable with high-end equipment, mass devices, computational-resource-limited platforms, and further scenarios.

Hansa Biopharma and German payer head association agree on reimbursement price for Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

Retrieved on: 
Tuesday, March 15, 2022
Survival, Immunoglobulin G, European Medicines Agency, Mortality, Commercial, Quality of life, Program, Patient, NUB, Nasdaq Stockholm, ESRD, EU, Hansa, AMNOG, State, Nasdaq, National Association, Chronic kidney disease, Risk, Dialysis, Kidney transplantation, EMA, Antibody, Hlas, Safety, Transplant, Degenerative disease, Medicine, Kidney disease, Company, Research, Cancer, CEO, DSA, Kidney failure, European Market Infrastructure Regulation, Priority, Kidney, European, Health insurance, Dentistry, Pharmaceutical industry, Medical device, Agency, Imlifidase

This completes, within the foreseen 12 month timeline, the AMNOG (Medicines Market Reorganization Act) process for Idefirix in Germany.

Key Points: 
  • This completes, within the foreseen 12 month timeline, the AMNOG (Medicines Market Reorganization Act) process for Idefirix in Germany.
  • At Hansa, our commitment is to significantly improve the lives of highly sensitized patients in Germany who are waiting for a potentially life-saving kidney transplant," says Sren Tulstrup, President and CEO, Hansa Biopharma.
  • "Highly sensitized kidney patients have previously had very limited access to kidney transplants due to the lack of effective desensitization treatments, and they often have no alternative but to remain on long-term dialysis."
  • Hansa has developed a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients.

Hansa Biopharma announces positive early access decision by French Haute Autorité de Santé to use Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

Retrieved on: 
Saturday, February 26, 2022
Risk, HAS, Kidney disease, Marketing, Company, Transplant, EU, European Medicines Agency, Nasdaq, Health technology assessment, Survival, Research, Priority, Degenerative disease, Safety, Hansa, Chronic kidney disease, Quality of life, Kidney failure, CEO, Program, National, Committee on National Security Systems, CSP, Population, Kidney transplantation, European, AP1, United Kingdom, Antibody, Kidney, AP2, Dialysis, EMA, HTA, Patient, Nasdaq Stockholm, Hlas, Commercial, European Market Infrastructure Regulation, ESRD, State, Medicine, Adult, Immunoglobulin G, DSA, Cancer, Pharmaceutical industry, Medical device, Dentistry, Agency, Imlifidase

LUND, Sweden, Feb. 26, 2022 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announces that its first-in-class treatment Idefirix® (imlifidase) has been granted early access post marketing authorization (Autorisation d'accès précoce) in France by French HAS (Haute Autorité de Santé) for use in the desensitization of highly sensitized adult patients prior to kidney transplant, in accordance with the patient population specified in the Marketing Authorization received from the European Medicines Agency (EMA).1,2

Key Points: 
  • The authorization has been granted based on Hansa's dossier submitted in December 2021, which rendered a positive opinion of the Transparency Commission.
  • Full details of the early access program can be found at the HAS website .
  • "Delivering Idefirixas a new therapy option for highly sensitized kidney patients in France demonstrates our commitment to improving the lives of patients with rare immunological conditions."
  • Hansa has developed a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients.

Pictet Asset Management and Finsemble Win WatersTechnology's 2021 Best Buy-Side Implementation Award

Retrieved on: 
Thursday, November 18, 2021
Automation, FIX, POC, Waters (magazine), Solution, Database, Communication, Money, Yahoo! Finance, E*TRADE, Efficiency, Citigroup, Java, Multimedia, European Market Infrastructure Regulation, OMS, FX, Risk management, Bank, Financial services, Online shopping

With its implementation, Pictet Asset Management has become a leader in buy-side interoperability.

Key Points: 
  • With its implementation, Pictet Asset Management has become a leader in buy-side interoperability.
  • "Pictet Asset Management is creating automated workflows never before seen at buy-side firms," says Cosaic CEO and co-founder Dan Schleifer.
  • Pictet Asset Management is an independently owned asset management company with assets under management of over 200 billion, offering multiple strategies across equity, multi-asset, FX and fixed income.
  • Pictet Asset Management is an independently owned asset management company with assets under management of over 200 billion.

Trustpilot Appoints Alicia Skubick as Chief Marketing Officer

Retrieved on: 
Tuesday, September 7, 2021
Other Consumer, Technology, Other Communications, Marketing, Advertising, Communications, Internet, Social Media, Consumer

Trustpilot , a leading online consumer reviews platform, announces the appointment of Alicia Skubick as Chief Marketing Officer, with effect from 04 October 2021.

Key Points: 
  • Trustpilot , a leading online consumer reviews platform, announces the appointment of Alicia Skubick as Chief Marketing Officer, with effect from 04 October 2021.
  • View the full release here: https://www.businesswire.com/news/home/20210907005525/en/
    Trustpilot appoints Alicia Skubick (Photo: Business Wire)
    Alicia Skubick joins Trustpilot to lead the Marketing function, within which she will be responsible for building the Trustpilot brand and growing the community of trust between consumers and businesses.
  • Prior to Trustpilot, Alicia was Marketing Director for the UK at financial management software company, Intuit Quickbooks.
  • Tim Hilpert, COO of Trustpilot, commented: We are thrilled to have Alicia Skubick join the Trustpilot senior leadership team at such a pivotal moment in time for the company.

Western Digital to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on August 4, 2021

Retrieved on: 
Tuesday, July 13, 2021
Semiconductor, Data management, Consumer electronics, Technology, Other Technology, Hardware, Financial markets, Feminine given names, American brands, Finance, Financial regulation, Corporate law, European Market Infrastructure Regulation, Systemic risk, European Union, NASDAQ, European Securities and Markets Authority, Esma

Western Digital Corp. (NASDAQ: WDC) plans to announce its fourth quarter and fiscal year 2021 financial results after the market closes on Wednesday, August 4, 2021.

Key Points: 
  • Western Digital Corp. (NASDAQ: WDC) plans to announce its fourth quarter and fiscal year 2021 financial results after the market closes on Wednesday, August 4, 2021.
  • The investment community conference call to discuss these results will be held that day at 1:30 p.m. Pacific / 4:30 p.m. Eastern.
  • The live audio webcast and a webcast replay of the conference call will be available at investor.wdc.com .
  • Our data-centric solutions are comprised of the Western Digital, G-Technology, SanDisk, and WD brands.

ESMA CONSULTS ON EMIR REPORTING GUIDELINES

Retrieved on: 
Wednesday, July 14, 2021
Financial regulation, Systemic risk, Corporate law, European Market Infrastructure Regulation, Business law, Economy, Articles, Financial markets, Derivative, Securities market, Trade Repository, Securities Financing Transactions Regulation

13 July 2021

Key Points: 
  • 13 July 2021

    Market data

    Post Trading

    Trade Repositories

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has today launched apublic consultation onits draft Guidelines for derivatives reporting under EMIR.

  • The Consultation Paper (CP) includes draft Guidelines on a wide range of topics related to reporting, data quality and data access under EMIR Refit.
  • The Consultation paper focuses on:

    The Draft Guidelines also clarify important aspects of the procedures to be implemented by reporting entities and Trade Repositories to enhance data quality.

  • The proposed Guidelines, together with the validation rules, complement the revised draft EMIR technical standards on reporting by counterparties, data quality and data access.

ESMA publishes methodology for assessing third country CCPs systemic importance

Retrieved on: 
Wednesday, July 14, 2021
Systemic risk, Finance, Financial markets, Settlement, Money, Financial regulation, Central counterparty clearing, Corporate law, European Market Infrastructure Regulation, Clearing

The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, today published a methodology for assessing whether a third country central counterparty (TC-CCP) or some of its clearing services are of such substantial systemic importance that the TC-CCP should not be recognised to provide certain clearing services or activities in the European Union.

Key Points: 
  • The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, today published a methodology for assessing whether a third country central counterparty (TC-CCP) or some of its clearing services are of such substantial systemic importance that the TC-CCP should not be recognised to provide certain clearing services or activities in the European Union.
  • The methodology has been developed by ESMAs CCP Supervisory Committee and is based on the requirements of Article 25 (2c) of EMIR.